Le Lézard
Classified in: Health, Business
Subject: CXP

Baltimore-Based Remedi SeniorCare Expands Technology-Enabled Pharmacy Services in Illinois


BALTIMORE, Jan. 21, 2020 /PRNewswire/ -- Chairman and CEO, Jeffrey M. Stamps, R.Ph., of Baltimore-based  Remedi SeniorCare, announces the opening of the company's newest PAXIT® pharmacy in Chicago, Illinois.  With the opening of its twelfth location, Remedi SeniorCare is licensed in 32 states and provides institutional pharmacy services to more than half the nation. The 50,000 square foot pharmacy will dispense Remedi's proprietary dispensing system PAXIT and eventually employ more than 200 individuals. "PAXIT is in high demand among our current and prospective customers, and we continue to expand to support that demand.  Remedi SeniorCare remains committed to our customer-focused approach and to expanding our geographic scope as an innovative and technology-enabled pharmacy service provider. We are eager to continue supporting long-term care growth in the Chicago and surrounding markets," said Mr. Stamps.

Remedi SeniorCare Pharmacy. (PRNewsFoto/Remedi SeniorCare)

A leading innovator in long-term care pharmacy, Remedi SeniorCare brings cutting-edge technology which is transforming the industry's service model.  As the exclusive provider of the patented PAXIT medication administration system, Remedi SeniorCare has a long history of providing cost-effective and highly accurate pharmacy med pass services to long-term care facilities, including skilled nursing facilities and assisted living communities.  On the assisted living front, PAXIT technology is driving the highest penetration levels in the industry, improving quality and continuity of care, which is critically important in electronic health record enabled communities. "PAXIT's unique 24-hour, unit-dose packaging, organized by med pass time, increases accuracy, efficiency, and safety in the med pass process, while reducing waste and cost for our skilled nursing and assisted living customers, their residents, and families," noted Mr. Stamps.    

The Remedi SeniorCare local management team is led by General Manager, Mike Milcarek, R.Ph., MBA, Operations Manager, Chris Frederick, Pharmacist-in-Charge, Shakil Bha, R.Ph., and Front End Manager, Danielle Risoldi.  These experienced pharmacists and operations professionals bring deep knowledge of the local market, having serviced the long-term care industry in numerous states for a number of years. "Our team is eager to provide a world-class pharmacy experience for our customers and to contribute to the company's legacy of innovation and excellence. We look forward to developing lasting partnerships with long-term care providers, residents, and family members," said Mr. Milcarek.

Remedi SeniorCare supports more than 80,000 residents across 32 states and the District of Columbia, with exceptional customer service, its patented PAXIT dispensing system, and proprietary MyRemedi® web portal.  Through its technology-enabled pharmacy services, Remedi SeniorCare allows its customers to achieve higher levels of accuracy and quality in medication delivery, while reducing unnecessary waste and cost.

For more information, visit www.RemediRx.com.

SOURCE Remedi SeniorCare


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: